Impact of Early Ureteric Stent Removal and Cost-Benefit Analysis in Kidney Transplant Recipients: Results of a Randomized Controlled Study

2012 ◽  
Vol 44 (3) ◽  
pp. 737-739 ◽  
Author(s):  
W. Parapiboon ◽  
A. Ingsathit ◽  
S. Disthabanchong ◽  
A. Nongnuch ◽  
A. Jearanaipreprem ◽  
...  
Keyword(s):  
Kidney Transplant ◽  
Cost Benefit Analysis ◽  
Cost Benefit ◽  
Controlled Study ◽  
Transplant Recipients ◽  
Benefit Analysis ◽  
Kidney Transplant Recipients ◽  
Ureteric Stent ◽  
Stent Removal ◽  
Randomized Controlled

scholarly journals Early ureteric stent removal reduces urinary tract infection in kidney transplant recipients: A randomized controlled trial

2017 ◽  
Vol 2 (1) ◽  
Author(s):  
Watanyu Parapiboon ◽  
Keeratipon Wiengpon ◽  
Chagriya Kitiyakara ◽  
Bunyong Phakdeekitcharoen ◽  
Charoen Leenanupunth ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
Urinary Tract Infection ◽  
Urinary Tract ◽  
Tract Infection ◽  
Controlled Trial ◽  
Transplant Recipients ◽  
Kidney Transplant Recipients ◽  
Ureteric Stent ◽  
Stent Removal ◽  
Randomized Controlled

scholarly journals High Mortality and Graft Loss After Infective Endocarditis in Kidney Transplant Recipients: A Case-Controlled Study From Two Centers

2021 ◽  
Author(s):  
Yanis Tamzali ◽  
Clément Danthu ◽  
Alexandra Aubry ◽  
Jean-François Faucher ◽  
Zhour El Ouafi ◽  
...  
Keyword(s):  
Infective Endocarditis ◽  
Kidney Transplant ◽  
Graft Loss ◽  
Controlled Study ◽  
Transplant Recipients ◽  
Kidney Transplant Recipients ◽  
Retrospective Case ◽  
Factors Associated ◽  
Streptococcus Gallolyticus ◽  
Duke Criteria

Purpose: Kidney Transplant Recipients (KTRs) tend to develop infections with characteristic epidemiology, presentation and outcome. While infective endocarditis (IE) is among such complications in KTRs, literature is scarce. We describe the presentation, epidemiology, and factors associated with IE in KTRs. Methods: We performed a retrospective case/control study which included patients from two centers. First episodes of definite or possible IE (Duke criteria), in adult KTRs from January 2007 to December 2018 were included, as well as two controls per case, and followed until December 31 2019. Clinical, biological, and microbiological data and the outcome were collected. Survival was studied using the Kaplan-Meier method. Finally, we searched for factors associated with the onset of IE in KTRs by the comparison of cases and controls. Results: Seventeen cases and 34 controls were included. IE was diagnosed after a mean delay of 78 months after KT, mostly on native valves of the left heart only. Pathogens of digestive origin were most frequently involved (six Enterococcus spp, three Streptococcus gallolyticus and one Escherichia coli), followed by Staphylococci (three cases of S. aureus and S. epidermidis each). Among the risk factors evaluated only age was significantly associated with the occurrence of IE in our study (63.8 years for cases vs. 55.6 years for controls, P=0.03) Patient and death-censored graft survival were greatly diminished five years after IE compared to controls being 50.3% vs. 80.6% (p<0.003) and 29.7% vs. 87.5% (p<0.002), respectively. Conclusion: IE in KTRs is a disease that carries significant risks both for the survival of the patient and the transplant.

Everolimus for BKV nephropathy in kidney transplant recipients: a prospective, controlled study.

2020 ◽  
Author(s):  
Elisabetta Bussalino ◽  
Luigina Marsano ◽  
Angelica Parodi ◽  
Rodolfo Russo ◽  
Fabio Massarino ◽  
...  
Keyword(s):  
Kidney Transplant ◽  
Controlled Study ◽  
Transplant Recipients ◽  
Kidney Transplant Recipients ◽  
Prospective Controlled Study
Sign in / Sign up

Export Citation Format

Share Document